Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.19.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 5,560 $ 123,476,102 $ (65,698,101) $ 57,783,561
Balance, shares at Dec. 31, 2017 55,603,427      
Issuance of common stock, net of issuance costs $ 150 11,194,482 11,194,632
Issuance of common stock, net of issuance costs, shares 1,500,000      
Stock compensation expense 1,884,916 1,884,916
Issuance of common stock upon exercise of stock options $ 4 156,651 156,655
Issuance of common stock upon exercise of stock options, shares 36,465      
Fair value of warrant issued in connection with Investment Agreement 6,215,225 6,215,225
Net loss (11,695,385) (11,695,385)
Balance at Mar. 31, 2018 $ 5,714 142,927,376 (77,393,486) 65,539,604
Balance, shares at Mar. 31, 2018 57,139,892      
Balance at Dec. 31, 2018 $ 5,725 148,888,635 (121,370,240) 27,524,120
Balance, shares at Dec. 31, 2018 57,247,496      
Issuance of common stock, net of issuance costs $ 620 37,718,078 $ 37,718,698
Issuance of common stock, net of issuance costs, shares 6,198,500     947,454
Stock compensation expense 3,088,939 $ 3,088,939
Issuance of common stock upon exercise of stock options $ 6 203,997 $ 204,003
Issuance of common stock upon exercise of stock options, shares 61,771     61,771
Issuance of common stock upon exercise of warrants $ 95 (95)
Issuance of common stock upon exercise of warrants, shares 947,454      
Net loss (26,234,809) (26,234,809)
Balance at Mar. 31, 2019 $ 6,446 $ 189,899,554 $ (147,605,049) $ 42,300,951
Balance, shares at Mar. 31, 2019 64,455,221